Medistim ASA (OSL: MEDI)
Norway
· Delayed Price · Currency is NOK
141.00
+2.00 (1.44%)
Nov 21, 2024, 4:25 PM CET
Medistim ASA Revenue
Medistim ASA had revenue of 132.76M NOK in the quarter ending September 30, 2024, with 6.98% growth. This brings the company's revenue in the last twelve months to 541.82M, up 2.83% year-over-year. In the year 2023, Medistim ASA had annual revenue of 521.11M with 7.17% growth.
Revenue (ttm)
541.82M
Revenue Growth
+2.83%
P/S Ratio
5.00
Revenue / Employee
3.59M
Employees
151
Market Cap
2.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 521.11M | 34.85M | 7.17% |
Dec 31, 2022 | 486.26M | 68.45M | 16.38% |
Dec 31, 2021 | 417.82M | 61.61M | 17.30% |
Dec 31, 2020 | 356.21M | -707.00K | -0.20% |
Dec 31, 2019 | 356.91M | 33.90M | 10.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 513.12M |
Carasent ASA | 264.80M |
Photocure ASA | 526.25M |
Nykode Therapeutics AS | 69.44M |
ArcticZymes Technologies ASA | 110.76M |
Gentian Diagnostics ASA | 154.12M |
Hofseth BioCare ASA | 248.08M |
Navamedic ASA | 525.55M |
Medistim ASA News
- 4 weeks ago - Medistim ASA (FRA:MD1) Q3 2024 Earnings Call Highlights: Strong Sales Growth in Americas Amid ... - GuruFocus
- 4 weeks ago - Q3 2024 Medistim ASA Earnings Call Transcript - GuruFocus